about
Genetics of Alzheimer's disease.Factors associated with degree of atopy in Latino children in a nationwide pediatric sample: the Genes-environments and Admixture in Latino Asthmatics (GALA II) studyPharmacogenetics of adverse reactions to antiepileptic drugs.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes.Pharmacogenetics and ethnicity: relevance for clinical implementation, clinical trials, pharmacovigilance and drug regulation in Latin America.Allele and genotype frequencies of genes relevant to anti-epileptic drug therapy in Mexican-Mestizo healthy volunteers.An update on HLA alleles associated with adverse drug reactions.Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and Mestizos from Chiapas.Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.The L444P GBA mutation is associated with early-onset Parkinson's disease in Mexican Mestizos.CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients.High frequency of Parkin exon rearrangements in Mexican-mestizo patients with early-onset Parkinson's disease.Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphismsInterethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics)Erratum: CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patientsVon Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastomaMutational spectrum of EDA and EDAR genes in a cohort of Mexican mestizo patients with hypohidrotic ectodermal dysplasiaInfluence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy
P50
Q33354698-7B7EB72B-264D-4A16-91E9-6A596DFA990EQ37209982-678225F4-94F0-4AFE-B7C8-B1EAB2972599Q38481885-9E72C6D4-8D69-41CC-9396-0F86F792770EQ38616806-06156817-4A4B-418B-8DCE-49CC97E99D9AQ38643436-C2664492-3616-431D-9630-F7DD3BFC0E20Q38803190-B8F7B90E-3923-456A-9062-791458DB7953Q38803195-4C2B97FB-127A-4FC5-92FA-B317A45130D8Q39186078-E7C4E530-162E-4152-B590-C4C95835C94FQ39947329-33F25818-E0D4-4940-AC60-739DFC41C71EQ41631036-C816B604-6710-48FD-8C8A-C64187C32F3DQ41704639-273AC60E-3C54-4D21-A9F3-64639CC0F0CFQ41704650-D0AE68F3-E77E-4760-8F88-4185E7FB030EQ44698182-B048097D-FCB0-42FB-975D-532D87C3A353Q44739431-545C442C-9A60-4D0D-9B9B-B989FEE2CA14Q48655811-9650BDE2-8F34-468C-AD0A-0F18D48F5DFBQ50254943-178F9E9B-3B56-4CF7-9364-C55C07FD803EQ57469260-2E34DF9B-766C-4604-B3E6-82A60E15B916Q57585527-88F70178-D509-49D7-BEC1-8335F2643973Q57585744-A7267371-D973-487A-8BF2-6C43B6F58EE5Q83009175-2105A26D-C66C-4AEC-ACA8-5D86B7AC5092Q89433051-3FAE00C0-1326-403E-BA5D-E46D29D41C80Q96126679-D1EFD4B4-7638-4402-849D-AC9F27611CB4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marisol López-López
@ast
Marisol López-López
@en
Marisol López-López
@es
Marisol López-López
@nl
type
label
Marisol López-López
@ast
Marisol López-López
@en
Marisol López-López
@es
Marisol López-López
@nl
prefLabel
Marisol López-López
@ast
Marisol López-López
@en
Marisol López-López
@es
Marisol López-López
@nl
P106
P1153
55539164700
P31
P496
0000-0002-3954-8052